327 related articles for article (PubMed ID: 30791717)
1. Vitamin A and Hydrochlorothiazide Causing Severe Hypercalcemia in a Patient With Primary Hyperparathyroidism.
Varghese RT; Khasawneh K; Desikan RK; Subramaniam A; Weaver T; Nair GKV
J Investig Med High Impact Case Rep; 2019; 7():2324709618823805. PubMed ID: 30791717
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia: A Review.
Walker MD; Shane E
JAMA; 2022 Oct; 328(16):1624-1636. PubMed ID: 36282253
[TBL] [Abstract][Full Text] [Related]
3. Thiazide-induced severe hypercalcemia: a case report and review of literature.
Desai HV; Gandhi K; Sharma M; Jennine M; Singh P; Brogan M
Am J Ther; 2010; 17(6):e234-6. PubMed ID: 20068444
[TBL] [Abstract][Full Text] [Related]
4. Suppressibility of parathyroid hormone in primary hyperparathyroidism.
Khoo TK; Baker CH; Abu-Lebdeh HS; Wermers RA
Endocr Pract; 2007; 13(7):785-9. PubMed ID: 18194938
[TBL] [Abstract][Full Text] [Related]
5. Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism?
Bargren AE; Repplinger D; Chen H; Sippel RS
J Am Coll Surg; 2011 Sep; 213(3):410-4. PubMed ID: 21723154
[TBL] [Abstract][Full Text] [Related]
6. Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.
Chandler PD; Scott JB; Drake BF; Ng K; Forman JP; Chan AT; Bennett GG; Hollis BW; Giovannucci EL; Emmons KM; Fuchs CS
Am J Med; 2014 Aug; 127(8):772-8. PubMed ID: 24657333
[TBL] [Abstract][Full Text] [Related]
7. Coexisting primary hyperparathyroidism and sarcoidosis in a patient with severe hypercalcemia.
Yoshida T; Iwasaki Y; Kagawa T; Sasaoka A; Horino T; Morita T; Hashimoto K
Endocr J; 2008 May; 55(2):391-5. PubMed ID: 18385529
[TBL] [Abstract][Full Text] [Related]
8. [Severe hypercalcemia after substitution of prolonged deficiency of vitamin D in a patient with primary hyperparathyroidism].
Duquenne M; Duquenne C; Souberbielle JC; Hamy A; Rohmer V
Presse Med; 2014 Dec; 43(12 Pt 1):1391-4. PubMed ID: 25443637
[No Abstract] [Full Text] [Related]
9. Management challenges with brown tumor of primary hyperparathyroidism masked by severe vitamin D deficiency: a case report.
Hussain M; Hammam M
J Med Case Rep; 2016 Jun; 10():166. PubMed ID: 27277007
[TBL] [Abstract][Full Text] [Related]
10. Normocalcemic hyperparathyroidism: Intervention to differentiate primary from secondary hyperparathyroidism.
Baugh KA; McCoy KL; Leung JH; Carty SE; Ramonell KM; Yip L
Surgery; 2024 Jan; 175(1):166-171. PubMed ID: 37981554
[TBL] [Abstract][Full Text] [Related]
11. Electrolytes: Calcium Disorders.
Barstow C; Braun M
FP Essent; 2017 Aug; 459():29-34. PubMed ID: 28806048
[TBL] [Abstract][Full Text] [Related]
12. Normocalcemic primary hyperparathyroidism.
Cusano NE; Silverberg SJ; Bilezikian JP
J Clin Densitom; 2013; 16(1):33-9. PubMed ID: 23374739
[TBL] [Abstract][Full Text] [Related]
13. Failure to Diagnose and Treat Hyperparathyroidism Among Patients with Hypercalcemia: Opportunities for Intervention at the Patient and Physician Level to Increase Surgical Referral.
Asban A; Dombrowsky A; Mallick R; Xie R; Kirklin JK; Grogan RH; Schneider DF; Chen H; Balentine CJ
Oncologist; 2019 Sep; 24(9):e828-e834. PubMed ID: 31019019
[TBL] [Abstract][Full Text] [Related]
14. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia induced by excessive intake of calcium supplement, presenting similar findings of primary hyperparathyroidism.
Kato Y; Sato K; Sata A; Omori K; Nakajima K; Tokinaga K; Obara T; Takano K
Endocr J; 2004 Dec; 51(6):557-62. PubMed ID: 15644574
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hypercalcemia in relation to hyperparathyroidism.
Pellitteri PK
Otolaryngol Clin North Am; 2010 Apr; 43(2):389-97, x. PubMed ID: 20510722
[TBL] [Abstract][Full Text] [Related]
17. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
18. [The short test with hydrochlorothiazide in differential diagnosis between primary normocalcemic and secondary hyperparathyroidism for inpatient treatment].
Eremkina AK; Elfimova AR; Aboisheva EA; Karaseva EV; Fadeeva MI; Maganeva IS; Kovaleva EV; Gorbacheva AM; Bibik EE; Mokrysheva NG
Probl Endokrinol (Mosk); 2022 Aug; 68(4):52-58. PubMed ID: 36104966
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and Management of Elevated Parathyroid Hormone Levels in Normocalcemic Patients.
Cusano NE
Med Clin North Am; 2021 Nov; 105(6):1135-1150. PubMed ID: 34688419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
